A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

A' is the same beast at heart that offers plenty to be excited about, despite falling short of its full potential.

Their emergence at the helm of Scotland’s biggest clubs now offers evidence that the Old Firm lack the gravitational pull of the past. Rangers used to hire managers like Paul Le ...

Gold, under DB’s analysis broken down below, is repricing because its ownership base has evolved from discretionary buyers to ...